← Back to Clinical Trials
Recruiting NCT06137339

AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults

Trial Parameters

Condition Brain Aging
Sponsor University of Kansas Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 70
Sex ALL
Min Age 65 Years
Max Age 85 Years
Start Date 2024-04-09
Completion 2025-12
Interventions
Avocado Group

Brief Summary

The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.

Eligibility Criteria

Inclusion Criteria: * Males and females aged 65-85 years * Good general health with no concomitant disease * BMI 18.5 - 35 kg/m2 * Mini Mental State Exam ≥26 * Reports consuming ≤2 medium avocados per month * Reports consuming ≤3 servings of carotenoid-rich foods per week and ≤3 servings of fruits and vegetables per day * Skin carotenoid content \<400 Exclusion Criteria: * Unwilling or unable to consume avocado * Latex allergy * Consistently taking lutein + zeaxanthin supplements * Skin carotenoid content ≥400 * Central neurological disease such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, brain tumor, etc. * Serious medical risk: cancer requiring chemotherapy or radiation within the past 5 years, recent cardiac event (i.e. heart attack, etc.) * Diabetes mellitus or uncontrolled hypertension * Use of psychoactive or investigational medications * Consumption of ≥3 alcoholic drinks per day or substance abuse * Unable to undergo MRI

Related Trials